Alx Oncology Holdings (ALXO) Current Leases (2021 - 2023)
Alx Oncology Holdings (ALXO) reported Current Leases of $777000.0 for Q1 2023, up 30.37% on a YoY basis from $596000.0 in Q1 2022, and up 2.91% sequentially from $755000.0 in Q4 2022.
Alx Oncology Holdings (ALXO) Current Leases (2021 - 2023) Analysis & Trends
Alx Oncology Holdings (ALXO) has 3 years of Current Leases data on file, last reported at $777000.0 in Q1 2023.
- For the quarter ending Q1 2023, Current Leases rose 30.37% year-over-year to $777000.0; the trailing twelve-month figure through Mar 2023 stood at $777000.0 (up 30.37% YoY), and the FY2022 full-year result was $755000.0, up 141.21% from the prior year.
- Current Leases advanced to $777000.0 in Q1 2023, from $755000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $777000.0 in Q1 2023 to a low of $313000.0 in Q4 2021.
- A 3-year average of $635166.7 and a median of $685000.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases jumped 141.21% in 2022 and surged 30.37% in 2023, its largest moves.
- Tracing ALXO's Current Leases over 3 years: stood at $313000.0 in 2021, then jumped by 141.21% to $755000.0 in 2022, then grew by 2.91% to $777000.0 in 2023.
- Business Quant data shows ALXO's Current Leases at $777000.0 in Q1 2023, $755000.0 in Q4 2022, and $724000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 755,000.00 |
| Sep 30, 2022 | 724,000.00 |
| Jun 30, 2022 | 646,000.00 |
| Mar 31, 2022 | 596,000.00 |
| Dec 31, 2021 | 313,000.00 |